-
First Global Maintains Market Perform Rating on Teva Pharmaceutical Industries
Monday, November 21, 2011 - 9:32amA report from First Global reiterates its Market Perform rating on Teva Pharmaceutical Industries (NASDAQ: TEVA). The report states, “We have maintained a rating of ‘ST MarketPerform' on Teva Pharmaceutical Industries Ltd. (Teva) since April 2011, in view of various near term concerns surrounding...
Read More >> -
First Global Reiterates Moderate Outperform Rating on Pfizer
Tuesday, August 23, 2011 - 8:03amFirst Global Research has published a research report on Pfizer Inc (NYSE: PFE). In the report, First Global wrote, "Pfizer Inc. (PFE) delivered a respectable performance for Q2 CY11 that met our expectations. The company's non-GAAP EPS of 60 cents for the quarter came in line with our estimate,...
Read More >> -
First Global Upgrades Johnson & Johnson To Moderate Outperform
Thursday, June 2, 2011 - 7:46amFirst Global has upgraded Johnon & Johnson (NYSE: JNJ) to Moderate Outperform.
Read More >> -
DELL Growth Prospects to Remain Weak
Tuesday, November 24, 2009 - 11:22amFirst Global US Research downgrades Dell Inc (NASDAQ: DELL) to “market perform.” DELL’s Q3 FY10 results had shocked the market, as the company had delivered one of its weakest performances over the past few quarters, First Global US Research said. With DELL’s sales declining 15% y/y and showing a...
Read More >>
